FDA approves nine generics for Lyrica drug
The FDA has announced that it has granted approval to the first nine generic drug applications for Pfizer’s Lyrica treatment.
List view / Grid view
The FDA has announced that it has granted approval to the first nine generic drug applications for Pfizer’s Lyrica treatment.
Chinese government introduces initiative to enable generic drugs to enter market and reduce prices.
A coalition of 43 attorneys general allege generic drug manufacturers colluded, overcharging US states and consumers billions.
The report, published from CPhI Japan 2019, highlights the country as the second fastest growing mature market for solid dose drugs.
Shortages of inexpensive, essential medicines: calling for tangible political commitments in the EU...
Executives blamed high drug prices on the drugmakers and their pursuit of profits...
The Food and Drug Administration has released a list of 40 drugs used to treat hypertension and heart failure that don’t contain any known carcinogens...
The FDA has prioritised the review of this drug application after multiple recalls of generic valsartan products from several manufacturers...
Colour-coded generics might help consumers differentiate between generics and branded medicines...
The EU is adopting new rules which should boost the competitiveness of EU producers of generic medicines and biosimilar products...
Of the 21 drugs designed for delivery directly to the female genital tract, only four have a cost-effective, generic equivalent...
The rising costs of brand-name drugs is largely driven by inflation in the prices of widely used existing drugs, according to a study published in the January issue of Health Affairs...
North America dominates the global market for pharmaceutical glass packaging, due to the region’s technical innovation and strong demand for pharmaceutical products...
The FDA has approved the first generic versions of Suboxone sublingual film for the treatment of opioid dependence...
A study in Canada has demonstrated that generic antiplatelet drugs appear to be as equally effective as a brand name drug for heart patients.